echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > A total of 2819 supplements to the medical insurance catalog of Shandong Province (with catalog attached)

    A total of 2819 supplements to the medical insurance catalog of Shandong Province (with catalog attached)

    • Last Update: 2018-03-30
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Source: sabilan 2018-03-30 Medical Network March 30 March 28, Shandong Provincial Department of human resources and social security issued the directory of industrial injury insurance and maternity insurance drugs for basic medical insurance of Shandong Province (2017 version), which was clearly implemented within one month from the date of publication, and the original 2010 version of the provincial directory was abolished at the same time It is reported that there are 2819 Chinese patent medicines and Western medicines (including 36 drugs negotiated by the state) in Shandong medical insurance catalogue, including 1456 Western medicines, 1363 Chinese patent medicines (including 91 ethnic medicines), only 7 varieties approved by work injury insurance fund for payment, and 4 varieties approved by birth insurance fund for payment Among them, 402 are class a western medicine, 192 are Chinese patent medicine, and the rest are class B medicine According to the notice, each overall planning area shall establish and improve the intelligent monitoring system for basic medical insurance medical services and the monitoring and analysis system for the use of social insurance drugs, focusing on the monitoring of drugs with large consumption, high expenditure and possible unreasonable use, and the monitoring results shall be released to the society in an appropriate way In addition, at the same time, it is clear that the drugs that mainly play the role of adjuvant treatment in class B drugs can appropriately increase the proportion of self payment of individuals and widen the gap with other class B drugs It can be seen that some key monitoring drugs, such as large dosage drugs and auxiliary drugs, also enter the monitoring scope of medical insurance Although up to now, the industry is no longer unfamiliar with the key monitoring and management of large dosage drugs and auxiliary drugs However, in the case of clear control of medical insurance, pharmaceutical companies still need to do a good job in the corresponding transformation and response strategies Appendix: details of supplementary varieties in Shandong medical insurance catalog western medicine supplementary varieties: Traditional Chinese medicine supplementary varieties: (source: collation by Yilian zhaocai.com)
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.